StockData
Parabilis Medicines, Inc. logo

Parabilis Medicines, Inc. (PBLS) KPIs and segments

PBLSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$28.25−0.20 (-0.70%)

Close on Nov 17, 2026Market cap $3.49BP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Parabilis Medicines's business

Coming soon

This tab will track the numbers specific to Parabilis Medicines's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?